Login / Signup

Reply: COVID-19 drug research and the cohort multiple randomised controlled trial design.

Raphael PorcherPhilippe RavaudMatthieu Resche-RigonPierre-Louis TharauxXavier MarietteOlivier Hermine
Published in: The European respiratory journal (2022)
Keyphrases
  • coronavirus disease
  • sars cov
  • study protocol
  • randomized controlled trial
  • adverse drug
  • respiratory syndrome coronavirus
  • emergency department
  • clinical trial
  • electronic health record